U.S. Pharmacy Market Size To Reach $708.9 Billion By 2030
U.S. pharmacy Market Growth & Trends
The U.S. pharmacy market size
is expected to reach USD 708.9 billion by 2030, according to a new report by
Grand View Research, Inc. The market is expected to expand at a CAGR of
3.67% from 2023 to 2030. This growth can be attributed to several factors,
including the increasing prevalence of chronic diseases, the aging population,
and expanding healthcare coverage, which leads to a higher demand for
healthcare services and medications. This expansion of healthcare coverage is
expected to provide more people with access to necessary medications.
In addition to these factors, the market players are introducing
improved services and transitioning towards e-pharmacy, which is expected to
contribute to market growth in the U.S. For instance, in February 2022,
Medicure Inc. launched its Marley drug pharmacy, which is a
direct-to-consumer e-commerce pharmacy platform. The platform offers
over 100 chronic care medications and free delivery to any location in the U.S.
and some territories. These developments are anticipated to have a positive impact
on market growth.
Furthermore, the number of pharmacies in the country for drug
distribution is increasing due to the rapid growth in the number of
prescriptions, which is expected to have a positive impact on market growth.
The National Council for Prescription Drug Programs (NCPDP) reported that the
number of independent pharmacies in the U.S. increased by 12.9% from 2010 to
2019. In 2010, there were 20,427 independent pharmacies in the U.S., while in
2019, there were 23,061. This increase in the number of independent pharmacies
is expected to contribute to the growth of the U.S. pharmacy industry.
Request a free sample copy or view the report summary: https://www.grandviewresearch.com/industry-analysis/us-pharmacy-market-report
U.S. Pharmacy Market Report Highlights
- Based on type,
the retail pharmacy segment held the largest market share in 2022 owing to
easy accessibility and the presence of multiple retail pharmacy chains
across the country
- Based on product
type, the prescription segment held the largest revenue share in 2022,
owing to the increasing burden of chronic diseases and the growing aging
population
- Based on the
ownership, the pharmacy chains segment held the largest market share in
2022 owing to the emergence of large hospital and corporation chains that
offer convenient and cost-effective services, including specialty drugs,
mail-order prescriptions, and other services
- The market has
witnessed significant vertical and horizontal consolidations in recent
years, which is expected to improve services
- The market
potential is driving a number of service providers to strengthen their
market presence by opening new centers and entering into partnerships. For
instance, in October 2021, Walgreens Boots Alliance (WBA) announced an
investment of USD 5.2 billion in VillageMD, a primary care provider. The
investment allow VillageMD to open 600 new primary care practices in over
30 US markets by 2025, more than half of which will be located in
underserved communities
U.S. Pharmacy Market Segmentation
Grand View Research has segmented the U.S. pharmacy market based
on pharmacy type, product type, and ownership:
U.S. Pharmacy Type Outlook (Revenue, USD Billion, 2018 -
2030)
- Hospital
Pharmacy
- Retail Pharmacy
- ePharmacy
- Others
U.S. Pharmacy Ownership Outlook (Revenue, USD Billion, 2018 -
2030)
- Independent
- Chain
U.S. Pharmacy Product Type Outlook (Revenue, USD Billion,
2018 - 2030)
- Prescription
- OTC
List of Key Players in the U.S. Pharmacy Market
- CVS Health
- Walgreens Boots
Alliance, Inc.
- Walmart Stores,
Inc
- Cigna Healthcare
- Rite Aid Corp
- The Kroger
Company
- Albertsons
Companies, Inc
- UnitedHealth
Group (OptumRx)
- Cardinal Health,
Inc
- Humana pharmacy
solution
Browse
Full Report: https://www.grandviewresearch.com/industry-analysis/us-pharmacy-market-report
Comments
Post a Comment